Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3225658 | 1.00 | MAPK1 (0.31) | MAPK1TDP1LMNAALOX15BLM | |
| Ammonia Solution, Strong SCHEMBL5698791 | 0.98 | MAPK1 (0.30) | MAPK1 | |
| SCHEMBL28289216 | 0.83 | LMNA (0.38) | LMNA | |
| SCHEMBL6726481 | 0.82 | KDM4E (0.32) | MAPK1TDP1LMNAALOX15BLM | |
| SCHEMBL28154184 | 0.82 | KDM4E (0.32) | MAPK1TDP1LMNAALOX15BLM | |
| SCHEMBL5690861 | 0.80 | — | — | |
| SCHEMBL337182 | 0.80 | MAPK1 (0.30) | MAPK1 | |
| SCHEMBL4531663 | 0.80 | MAPK1 (0.30) | MAPK1 | |
| SCHEMBL11503593 | 0.80 | TRPA1 (0.31) | MAPK1 | |
| SCHEMBL11503592 | 0.80 | TRPA1 (0.31) | MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0216147-A2 | Covalently crosslinked copolymer absorbent | HENKEL CORPORATION (a Delaware corp.) (US) | 1987-04-01 | — | — | EP | claimed |
| US-20150059238-A1 | USE OF COLD FLOW IMPROVER COMPOSITIONS FOR FUELS, BLENDS THEREOF WITH BIOFUELS AND FORMULATIONS THEREOF | EVONIK OIL ADDITIVES GMBH (DE) | 2015-03-05 | — | — | US | disclosed |
| EP-2841538-A1 | USE OF COLD FLOW IMPROVER COMPOSITIONS FOR FUELS, BLENDS THEREOF WITH BIOFUELS AND FORMULATIONS THEREOF | Evonik Oil Additives GmbH (DE) | 2015-03-04 | — | — | EP | disclosed |
| US-8962231-B2 | Toner for magnetic single-component development | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2015-02-24 | — | — | US | disclosed |
| US-20130344429-A1 | TONER FOR MAGNETIC SINGLE-COMPONENT DEVELOPMENT | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2013-12-26 | — | — | US | disclosed |
| EP-2677366-A1 | Toner for magnetic single-component development | Kyocera Document Solutions Inc. (JP) | 2013-12-25 | — | — | EP | disclosed |
| WO-2013160228-A1 | USE OF COLD FLOW IMPROVER COMPOSITIONS FOR FUELS, BLENDS THEREOF WITH BIOFUELS AND FORMULATIONS THEREOF | EVONIK OIL ADDITIVES GMBH (DE) | 2013-10-31 | — | — | WO | disclosed |
| US-8303943-B2 | Ampholytic copolymer based on quaternized nitrogen-containing monomers | BASF SE (DE) | 2012-11-06 | — | — | US | disclosed |
| US-20100068156-A1 | AMPHOLYTIC COPOLYMER BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | BASF SE (DE) | 2010-03-18 | — | — | US | disclosed |
| EP-2064253-B1 | AMPHOLYTIC COPOLYMER BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | BASF SE (DE) | 2009-11-18 | — | — | EP | disclosed |
| EP-0472352-B1 | Sludge treatment | BETZ EUROP INC (US) | 1995-01-04 | — | — | EP | disclosed |
| US-5108622-A | Block copolymers for sludge dewatering and a polymeric initiator for their preparation | BETZ LABORATORIES, INC. (US) | 1992-04-28 | — | — | US | disclosed |
| EP-0472352-A1 | Sludge treatment | BETZ EUROPE, INC. (US) | 1992-02-26 | — | — | EP | disclosed |
| EP-0216147-A2 | Covalently crosslinked copolymer absorbent | HENKEL CORPORATION (a Delaware corp.) (US) | 1987-04-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100068156-A1 | AMPHOLYTIC COPOLYMER BASED ON QUATERNIZED NITROGEN-CONTAINING MONOMERS | NGLY1, NAAA, NIT2 | MAPK1 1440/4885TDP1 1288/4885LMNA 3739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.